ASPN vs FSTR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits severe financial distress with a Piotroski F-Score of just 2/9, indicating weak financial health. Despite a strong current ratio and low debt/equity, profitability is deeply negative, with a profit margin of -86.52% and ROE of -75.06%. Revenue has collapsed by 37.8% year-over-year, and while recent quarters show erratic earnings surprises, the long-term trend is one of deterioration. The stock trades significantly below its 52-week high with a bearish technical trend and negative insider sentiment, reinforcing fundamental weaknesses.
FSTR exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and a conservative debt-to-equity ratio of 0.41. However, there is a severe divergence between its fundamental value (Graham Number: $16.39, Intrinsic Value: $4.83) and its current market price of $29.97. While revenue growth is robust at 25.10%, the company has failed to beat earnings estimates in the last four quarters, with an average surprise of -48.78%. The combination of bearish insider selling and a weak technical trend offsets the strong balance sheet and growth potential.
Compare Another Pair
Related Comparisons
ASPN vs FSTR: Head-to-Head Comparison
This page compares Aspen Aerogels, Inc. (ASPN) and L.B. Foster Company (FSTR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.